Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy

American Surgeon

Volumn 68, Issue 9, 2002, Pages 827-831

  Bloomston, Mark ^a   Binitie, Odion ^a   Fraiji, Elie ^a   Murr, Michel ^a   Zervos, Emmanuel ^a   Goldin, Steven ^a   Kudryk, Bruce ^a,b   Zwiebel, Bruce ^a,b   Black, Thomas ^a,b   Fargher, Scott ^b   Rosemurgy, Alexander S ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Radiology Associates of Tampa   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; ETHIODIZED OIL; MITOMYCIN; POLYVINYL ALCOHOL;

ABSENCE OF SIDE EFFECTS; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; HEMATOMA; HUMAN; LIVER CELL CARCINOMA; LIVER METASTASIS; MALE; RADIOFREQUENCY ABLATION; SURVIVAL TIME; TREATMENT OUTCOME; TREATMENT REFUSAL; CATHETER ABLATION; COLORECTAL TUMOR; LIVER TUMOR; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL RATE;

CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0036730805     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Fan ST, Ng IO, Poon RT, et al. Hepatectomy for hepatocellular carcinoma: The surgeon's role in long-term survival. Arch Surg 1999;134:1124-30.
2. Mazziotti A, Grazi GL, Cavallari A. Surgical treatment of hepatocellular carcinoma on cirrhosis: A Western experience. Hepatogastroenterology 1998;45(Suppl 3):1281-7.
3. Tsuzuki T, Sugioka A, Ueda M, et al. Hepatic resection for hepatocellular carcinoma. Surgery 1990;107:511-20.
4. Blumgart LH, Fong Y. Surgical options in the treatment of hepatic metastasis from colorectal cancer. Curr Probl Surg 1995; 32:333-421.
5. Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997;15:938-46.
6. Hughes KS, Simon R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of patterns of recurrence. Surgery 1986;100:278-84.
7. Ardalan B, Luis R, Jaime M, Franceschi D. Biomodulation of fluorouracil in colorectal cancer. Cancer Invest 1998;16:237-51.
8. Skibber JM, Minsky BD, Hoff PM. Cancer of the Colon. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. Philadelphia: Lippincott Williams and Wilkins, 2001, pp 1257-63.
9. Mathurin P, Rixe O, Carbonell N, et al. Review article: Overview of medical treatments in unresectable hepatocellular carcinoma-an impossible meta-analysis? Aliment Pharmacol Ther 1998;12:111-26.
10. Simonetti RG, Liberati A, Angiolini C, Pagliaro L. Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials. Ann Oncol 1997;8:117-36.
11. Matsukawa T, Yamashita Y, Arakawa A, et al. Percutaneous microwave coagulation therapy in liver tumors: A 3-year experience. Acta Radiol 1997;38:410-5.
12. Seki T, Tamai T, Nakagawa T, et al. Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma. Cancer 2000;89:1245-51.
13. Bilchik AJ, Sarantou T, Wardlaw JC, Ramming KP. Cryosurgery causes a profound reduction in tumor markers in hepatoma and noncolorectal hepatic metastases. Am Surg 1997;63:796-800.
14. Aguayo A, Patt YZ. Nonsurgical treatment of hepatocellular carcinoma. Semin Oncol 2001;28:503-13.
15. Rose DM, Chapman WC, Brockenbrough AT, et al. Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma. Am J Surg 1999;177:405-10.
16. Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: Results in 123 patients. Ann Surg 1999;230:1-8.
17. Kato T, Reddy KR. Radiofrequency ablation for hepatocellular carcinoma: Help or hazard? Hepatology 2001;33:1336-7.
18. Bismuth H, Majno PE, Adam R. Liver transplantation for hepatocellular carcinoma. Semin Liver Dis 1999;19:311-22.
19. Arcement CM, Towbin RB, Meza MP, et al. Intrahepatic chemoembolization in unresectable pediatric liver malignancies. Pediatr Radiol 2000;30:779-85.
20. Gores GJ. Chemoembolization as a bridge to transplantation for hepatocellular carcinoma. Liver Transpl 2001;7:998.
21. Bartolozzi C, Lencioni R, Caramella D, et al. Hepatocellular carcinoma: CT and MR features after transcatheter arterial embolization and percutaneous ethanol injection. Radiology 1994; 191:123-8.
22. Murakami T, Nakamura H, Hori S, et al. Detection of viable tumor cells in hepatocellular carcinoma following transcatheter arterial chemoembolization with iodized oil: Pathologic correlation with dynamic turbo-FLASH MR imaging with Gd-DTPA. Acta Radiol 1993;34:399-403
23. Catalano O, Lobianco R, Esposito M, Siani A. Hepatocellular carcinoma recurrence after percutaneous ablation therapy: Helical CT patterns. Abdom Imaging 2001;26:375-83.
24. Tsuda M, Majima K, Yamada T, et al. Hepatocellular carcinoma after radiofrequency ablation therapy: Dynamic CT evaluation of treatment. Clin Imaging 2001;25:409-15.
25. Bayraktar Y, Balkanci F, Kayhan B, et al. A comparison of chemoembolization with conventional chemotherapy and symptomatic treatment in cirrhotic patients with hepatocellular carcinoma. Hepatogastroenterology 1996;43:681-7.
26. Solomon B, Soulen MC, Baum RA, et al. Chemoembolization of hepatocellular carcinoma with cisplatin, doxorubicin, mitomycin-C, ethiodol, and polyvinyl alcohol: Prospective evaluation of response and survival in a U.S. population. J Vasc Interv Radiol 1999;10:793-8.
27. Podnos YD, Henry G, Ortiz JA, et al. Laparoscopic ultrasound with radiofrequency ablation in cirrhotic patients with hepatocellular carcinoma: Technique and technical considerations. Am Surg 2001;67:1181-4.
28. Chung MH, Wood TF, Tsioulias GJ, et al. Laparoscopic radiofrequency ablation of unresectable hepatic malignancies: A phase 2 trial. Surg Endosc 2001;15:1020-6.
29. Chinn SB, Lee FT Jr, Kennedy GD, et al. Effect of vascular occlusion on radiofrequency ablation of the liver: Results in a porcine model. AJR Am J Roentgenol 2001;176:789-95.